Related Experiment Video
Updated: Feb 11, 2026

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Evaluation of hearing level in patients on long term aspirin therapy
Apar Pokharel1, Sangita Bhandary1
1ENT Department, College of Medical Sciences, Bharatpur, Chitwan, Nepal.
Insights
Aspirin, commonly used for heart conditions, does not cause hearing loss or tinnitus. Advanced age is a more significant risk factor for hearing impairment than aspirin therapy.
Area of Science:
- Audiology
- Cardiology
- Pharmacology
Background:
- Aspirin is frequently prescribed for cardiovascular diseases like myocardial ischemia.
- The potential ototoxic effects of aspirin therapy require investigation.
Purpose of the Study:
- To compare hearing status in cardiovascular disease patients on long-term aspirin therapy versus age-matched controls.
- To determine if aspirin intake is associated with hearing loss or tinnitus.
Main Methods:
- A cross-sectional, comparative study involving 182 patients on long-term aspirin and 221 age-matched controls not taking aspirin.
- Evaluation of hearing status in both groups.
Main Results:
- Age was identified as a more significant risk factor for hearing loss than aspirin intake.
- No significant difference in audiological problems was observed between the groups when controlling for confounding factors.
Conclusions:
- Low-dose, antiplatelet aspirin therapy is not associated with hearing loss or tinnitus.
- Age, hypertension, and diabetes are more critical factors influencing hearing status in patients with cardiovascular disease.
Abstract:
Introduction: Aspirin is a routinely prescribed drug, most notably for cardiovascular diseases, such as myocardial ischemia. This cross sectional, comparative study study aims to explore differences in hearing status between the cardiovascular disease patients on aspirin therapy and age matched controls. Methods: The study population consisted of 182 patients with heart disease taking long term aspirin (i.e., for more than one year). The control population consisted of 221 age matched controls who were not taking aspirin. Results: It was found that age of patient, not aspirin intake, was more important risk factor contributing to hearing loss. Conclusions: When confounding factors like age of the patient, hypertension and diabetes were taken into account, aspirin in its antiplatelet dose was not found to be the cause of any audiological problems like tinnitus and hearing loss.
Related Concept Videos
Hearing
Long-term Depression
Leveling Effect
Gene Therapy
High-Level and Low-Level Awareness
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...

